edoc

Items where contributor is "Bernhard, Sonja"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: Yes

Yes

Bernhard, S. and Kaiser, M. and Burri, C. and Mäser, P.. (2022) Fexinidazole for human African trypanosomiasis, the fruit of a successful public-private partnership. Diseases, 10 (4). p. 90.

Kande Betu Kumesu, V. and Mutombo Kalonji, W. and Bardonneau, C. and Valverde Mordt, O. and Ngolo Tete, D. and Blesson, S. and Simon, F. and Delhomme, S. and Bernhard, S. and Nganzobo Ngima, P. and Mahenzi Mbembo, H. and Fina Lubaki, J. P. and Lumeya Vuvu, S. and Kuziena Mindele, W. and Ilunga Wa Kyhi, M. and Mandula Mokenge, G. and Kaninda Badibabi, L. and Kasongo Bonama, A. and Kavunga Lukula, P. and Lumbala, C. and Scherrer, B. and Strub-Wourgaft, N. and Tarral, A.. (2022) Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2-3 trial. Lancet Glob Health, 10 (11). e1665-e1674.

Kümmerle, A. and Schmid, C. and Bernhard, S. and Kande, V. and Mutombo, W. and Ilunga, M. and Lumpungu, I. and Mutanda, S. and Nganzobo, P. and Tete, D. N. and Kisala, M. and Burri, C. and Blesson, S. and Valverde Mordt, O.. (2021) Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: report from a field study. PLoS Negl Trop Dis, 15 (11). e0009903.

Mesu, V. K. B. K. and Mutombo Kalonji, W. and Bardonneau, C. and Valverde Mordt, O. and Ngolo Tete, D. and Blesson, S. and Simon, F. and Delhomme, S. and Bernhard, S. and Mahenzi Mbembo, H. and Mpia Moke, C. and Lumeya Vuvu, S. and Mudji E'kitiak, J. and Akwaso Masa, F. and Mukendi Ilunga, M. and Mpoyi Muamba Nzambi, D. and Mayala Malu, T. and Kapongo Tshilumbwa, S. and Botalema Bolengi, F. and Nkieri Matsho, M. and Lumbala, C. and Scherrer, B. and Strub-Wourgaft, N. and Tarral, A.. (2021) Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study. Lancet Glob Health, 9 (7). e999-e1008.

Mesu, Victor Kande Betu Ku and Kalonji, Wilfried Mutombo and Bardonneau, Clélia and Mordt, Olaf Valverde and Blesson, Séverine and Simon, François and Delhomme, Sophie and Bernhard, Sonja and Kuziena, Willy and Lubaki, Jean-Pierre Fina and Vuvu, Steven Lumeya and Ngima, Pathou Nganzobo and Mbembo, Hélène Mahenzi and Ilunga, Médard and Bonama, Augustin Kasongo and Heradi, Josué Amici and Solomo, Jean Louis Lumaliza and Mandula, Guylain and Badibabi, Lewis Kaninda and Dama, Francis Regongbenga and Lukula, Papy Kavunga and Tete, Digas Ngolo and Lumbala, Crispin and Scherrer, Bruno and Strub-Wourgaft, Nathalie and Tarral, Antoine. (2018) Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. Lancet, 391 (10116). pp. 144-154.